New ESC guidelines integrate management of aortic and peripheral arterial diseases

The 2024 ESC Guidelines for the management of peripheral arterial and aortic diseases (PAAD) evaluate these vascular diseases together as part of same cardiovascular system, appreciating that patients with aortic diseases are at risk of having peripheral vascular diseases and vice versa.

BMS buys Mirati for $4.8B; Pfizer to slash cost; Q&A with Vertex CSO; Alnylam’s Onpattro setback; and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit

October 15, 2023

Odesza at Folsom Field ushers in a new concert era for CU Boulder – The Cannabist

If anyone in Boulder hears a rumbling sound emanating from the University of Colorado Boulder campus this weekend, fear not. No volcano is brewing. It’s

June 28, 2024

Secarna Announces Appointment of Konstantin Petropoulos as Chief Executive Office – Biotech Investments

EQS-News: Secarna Pharmaceuticals GmbH & Co. KG / Key word(s): Personnel Secarna Announces Appointment of Konstantin Petropoulos as Chief Executive Office 31.10.2024 / 16:03 CET/CEST

November 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.